FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
423 letters match. Newest first.
-
DrugsSovereign Pharmaceuticals, LLC
FDA cited Sovereign Pharmaceuticals for manufacturing failures in bulk tablets, inadequate out-of-specification (OOS) investigations, quality-unit lapses, and an unapproved biological product.
High risk -
DrugsLakpura LLC
FDA and Federal Trade Commission warned Lakpura LLC over ayurvedic products and teas with unapproved COVID-19 claims.
High risk -
AnimalSouth Pork Ranch Equipment LLC
South Pork Ranch Equipment marketed unapproved Cydectin and Blackstrap animal drugs for treating disease in goats, sheep, and cattle online.
High risk -
DevicesFlawless Beauty and Skin
FDA says Flawless Beauty and Skin marketed unapproved microneedling devices and failed to register as an initial importer.
Medium -
DrugsBespoke Apothecary LLC
Bespoke Apothecary sold COVID kit and herbal tea with unapproved COVID-19 treatment claims, FDA and FTC say.
Low -
FoodMuscle Sports Products, LLC
Muscle Sports Products sold supplements as unapproved new drugs with disease claims, including COVID-19, FDA says.
High risk -
FoodThe Elderberry Fairy & Co., LLC
FDA warns The Elderberry Fairy & Co. that elderberry syrups and Organic Fire Cider are unapproved new drugs and misbranded.
Low -
DevicesUSA Medical LLC
FDA: USA Medical sold unapproved COVID-19 antigen tests with false EUA claims and lacked basic quality system procedures.
High risk -
DrugsAriella Naturals
FDA warned Ariella Naturals that its website sells unapproved mole and skin tag removal drugs without FDA approval.
High risk -
DrugsAmazon.com, Inc.
Amazon distributes unapproved new drugs for mole and skin tag removal, FDA says.
High risk -
BiologicsVitti Labs, LLC
FDA warns Vitti Labs over unapproved umbilical cord and amniotic membrane products and sterile manufacturing failures.
High risk -
DrugsFluxxLab LLC
FDA and FTC warned FluxxLab that its COVID-19 and CBDA/CBD tinctures are unapproved, misbranded drugs marketed with unsupported COVID-19 claims.
High risk -
DrugsCustom Research Labs Inc.
FDA warned Custom Research Labs Inc. about manufacturing-practice violations and unapproved, misbranded OTC drugs, including hand sanitizers and topical analgesics.
High risk -
FoodLiving Foods LLC
FDA warned Living Foods LLC that its Bion+Plus, ZeoHeal and Relax Sauna were marketed with unapproved drug and device claims.
High risk -
FoodH2 Beverages, Inc.
H2 Beverages' hydrogen-infused water beverages are unapproved new drugs and misbranded because of disease and COVID-19 claims.
High risk -
DrugsElite Supplement Center LLC and Elite Training Facility LLC
FDA warned Elite Supplement Center that it sells five SARM products as unapproved new drugs for human use.
High risk -
FoodThirsty Run LLC / US Royal Honey LLC
FDA found hidden Viagra and Cialis ingredients in three royal honey products sold online as supplements and drugs.
High risk -
DrugsDDI Multinacional S.A. de C.V.
DDI Multinacional hand sanitizers labeled 70% ethanol contained up to 60% methanol, leading to adulteration and import alert.
High risk -
DrugsHerbsens Botanicals
Herbsens Botanicals marketed kratom capsules and powders as unapproved drugs to treat opioid addiction and other conditions.
High risk -
DrugsKratom Exchange
FDA and FTC warned Kratom Exchange that it sells kratom as unapproved new drugs for opioid addiction and other conditions.
High risk -
DrugsOmni Consumer Products LLC d/b/a YoKratom
FDA and FTC warned YoKratom that its kratom products are unapproved new drugs marketed to treat opioid addiction.
High risk -
DrugsMONQ, LLC
MONQ sold unapproved inhalation essential oil products with claims to treat opioid addiction and withdrawal, FDA and FTC said.
High risk -
DrugsIndustrias Cklass S. de R.L. de C.V.
FDA found Industrias Cklass hand sanitizer labeled 70% ethanol contained 19% ethanol and 48% methanol and was refused U.S. admission.
High risk -
FoodGolden Lab LLC
Golden Lab sold eye and allergy capsules with unapproved drug claims and lacked required supplement manufacturing controls.
High risk -
AnimalEquine Podiatry Solutions, LLC
Equine Podiatry Solutions marketed Desmosphyrine, an unapproved new animal drug, for treating laminitis in horses.
High risk -
AnimalHaniel Concepts, Inc. DBA Free State Oils, LLC
FDA warned Free State Oils over website claims that its CBD products treat disease, including COVID-19, and are unapproved drugs and adulterated foods.
High risk -
DrugsAyuryoga, Inc.
FDA warned Ayuryoga/Kottakkal Ayurveda USA that its ayurvedic products are unapproved new drugs promoted with disease-treatment claims online.
High risk -
DrugsSanthigram Kerala Ayurvedic Co. of U.S., Inc.
FDA told Santhigram Kerala Ayurvedic Co. of U.S. that its ayurvedic products are unapproved new drugs sold with disease claims online.
High risk -
DrugsInhousepharmacy.vu
Vanuatu online pharmacy Inhousepharmacy.vu sold unapproved domperidone to US consumers over the internet.
High risk -
DrugsDelta 8 Hemp
FDA warned Delta 8 Hemp over unapproved Delta-8 THC drugs and adulterated gummies sold online.
High risk -
DrugsATLRx, Inc.
FDA warned ATLRx that its CBD and Delta-8 THC products are unapproved drugs with illegal disease claims.
High risk -
FoodMYA International, Inc.
FDA warned MYA International that its supplement and herbal product labels made unapproved drug claims and its dietary supplements violated manufacturing quality and labeling rules.
High risk -
FoodRena's Organic
U.S. Food and Drug Administration (FDA) warned Rena's Organic over unapproved CBD drug claims for tinctures, creams, foods, and pet product.
High risk -
DrugsGuangzhou Zhongkebaishi Health Industry Co., Ltd.
Guangzhou Zhongkebaishi's Hand Sanitizer Gel, labeled 75% ethanol, tested at 51% and was refused US import.
High risk -
DrugsKleenhanz, LLC
FDA told Kleenhanz its antiseptic towelettes were unapproved drugs because the website and Twitter claimed they fight COVID-19 and other diseases.
High risk -
DrugsElements Brands Inc.
FDA warned Elements Brands that its eb5 Skin Lightening Cream is an unapproved, misbranded new drug.
High risk -
DrugsSkinPro
SkinPro sells an unapproved, misbranded hydroquinone skin-bleaching drug without FDA approval.
High risk -
DrugsNeoteric Cosmetics, Incorporated/Scott’s Liquid Gold, Inc.
FDA warned Neoteric Cosmetics and parent Scott's Liquid Gold that ALPHA Skin Care Dual Action Fade Cream, a hydroquinone skin lightener, is an unapproved and misbranded drug.
Medium -
DrugsSkin Authority, L.L.C.
FDA warns Skin Authority that its skinauthority Hyperpigmentation Treatment is an unapproved and misbranded skin-bleaching drug.
High risk -
DrugsGenomma Lab USA, Inc.
Genomma Lab USA sold two hydroquinone skin-lightening creams as unapproved and misbranded new drugs, FDA says.
High risk -
DrugsTrue Earth Health Products, LLC
FDA warned True Earth Health Products over Plexaderm Dark Spot Fade Gel, an unapproved, misbranded hydroquinone skin-bleaching drug.
High risk -
Drugswww.wellerectile.com
FDA warned India-based www.wellerectile.com over selling unapproved, improperly labeled drugs online, including hydroxychloroquine claimed to treat COVID-19.
High risk -
DrugsCofixRx, LLC
FDA warned CofixRx that its CofixRX Nasal Spray is an unapproved, misbranded drug sold with COVID-19 prevention claims.
High risk -
DrugsNDAL Mfg Inc.
NDAL Mfg's honey nasal sprays had manufacturing-rule violations, microbial contamination, and lacked FDA approval as new drugs.
High risk -
FoodHoney Feast, Inc.
Honey Feast, Inc. sold honey products online with disease-treatment claims, making them unapproved new drugs and misbranded.
Low -
DrugsFunctional Remedies, LLC D/B/A Synchronicity Hemp Oil
FDA and FTC told a Louisville, Colorado hemp and CBD seller that its website claims the products treat or prevent COVID-19, making them unapproved and misbranded drugs.
High risk -
DrugsGreenway Herbal Products LLC
FDA and FTC warned GreenWay Herbal Products that CBD website claims to prevent and treat COVID-19 make its products unapproved, misbranded drugs.
High risk -
DrugsCureganics
Cureganics sold CBD products with website claims they prevent or treat COVID-19, making them unapproved and misbranded drugs.
High risk -
DrugsNature's Highway
FDA and FTC warned CBD seller Nature's Highway for selling unapproved drugs claimed to treat or prevent COVID-19.
High risk -
DrugsUPSY LLC
FDA and FTC warned UPSY LLC that its website sells CBD products claimed to treat or prevent COVID-19 as unapproved, misbranded drugs.
High risk